Scan to download
BTC $60,958.94 -1.56%
ETH $1,569.91 -5.77%
BNB $575.76 -3.10%
XRP $1.09 -2.68%
SOL $62.83 -5.12%
TRX $0.3205 -1.51%
DOGE $0.0819 -2.48%
ADA $0.1584 -3.33%
BCH $217.25 -2.30%
LINK $7.38 -2.74%
HYPE $59.23 -4.92%
AAVE $62.11 -4.76%
SUI $0.7181 +0.27%
XLM $0.2017 +6.32%
ZEC $374.35 +17.57%
BTC $60,958.94 -1.56%
ETH $1,569.91 -5.77%
BNB $575.76 -3.10%
XRP $1.09 -2.68%
SOL $62.83 -5.12%
TRX $0.3205 -1.51%
DOGE $0.0819 -2.48%
ADA $0.1584 -3.33%
BCH $217.25 -2.30%
LINK $7.38 -2.74%
HYPE $59.23 -4.92%
AAVE $62.11 -4.76%
SUI $0.7181 +0.27%
XLM $0.2017 +6.32%
ZEC $374.35 +17.57%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41
Collection

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.